In the published article, there was an error regarding the contribution of “Xinsheng Yao,” who should be a co-corresponding author.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
Shikonin, anticancer effect, cell cycle arrest, autophagy, apoptosis, P21
Citation
Wang F, Mayca Pozo F, Tian D, Geng X, Yao X, Zhang Y and Tang J (2020) Corrigendum: Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction. Front. Pharmacol. 11:1088. doi: 10.3389/fphar.2020.01088
Received
29 June 2020
Accepted
03 July 2020
Published
16 July 2020
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
11 - 2020
Updates
Copyright
© 2020 Wang, Mayca Pozo, Tian, Geng, Yao, Zhang and Tang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xinsheng Yao, tyaoxs@jnu.edu.cn; Youwei Zhang, yxz169@case.edu; Jinshan Tang, gztangjinshan@126.com
This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.